海外の治験の状況「1」での検索結果
8489件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- Clinical Trial Testing the efficacy and Safety of Two Ramucirumab Doses Given as Second Line Treatment to Patients with Stomach Cancer
- Second-Line Metastatic or Locally Advanced, Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma MedDRA version: 20.0 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, Czech Republic, Germany, Greece, Spain, Sweden, Turkey, Ukraine, United States
- 2015-06-09
Not Recruiting
- Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
- Kidney Transplantation # Chronic Kidney Failure;N18 - Chronic kidney disease
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Mexico, Poland, South Africa, Spain, Sweden, Switzerland, Turkey, United States
- 2015-04-14
Not recruiting
- DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA
- Psoriatic Arthritis;Psoriatic Arthritis;Psoriatic Arthritis;Psoriatic Arthritis
- United States
- 2015-04-07
Not Recruiting
- A clinical trial demonstrating the safety and efficacy of treatment of lines between the eye brows with the test drug DWP-450 in adults by comparison with Botox and Placebo.
- moderate-to-severe glabellar lines br>MedDRA version: 17.1 Level: LLT Classification code 10052609 Term: Glabellar frown lines System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Canada, France, Germany, Sweden, United Kingdom
- 2015-03-20
Not recruiting
- A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
- Recurrent Head and Neck Cancer;Metastatic Head and Neck Cancer
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2015-02-03
Not recruiting
- A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
- Myelodysplastic Syndrome
- United States
- 2015-01-21
Not recruiting
- Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy
- Estrogen Receptor Positive Breast Cancer;Estrogen Receptor Positive Breast Cancer;Estrogen Receptor Positive Breast Cancer;Estrogen Receptor Positive Breast Cancer
- United States
- 2015-01-19
Not recruiting
- Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy
- Metastatic Urothelial Carcinoma (UC)
- United States
- 2015-01-06
Not Recruiting
- A multicenter, randomized, double blind, parallel group, vehicle controlled, study of the safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 8 weeks in pediatric subjects (2 to 12 years of age) with mild to moderate plaque psoriasis
- Psoriasis;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Belgium, Canada, Germany, Hungary, Italy, Spain, United States
- 2014-10-28
Not recruiting
- Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
- Cholangiocarcinoma;Cholangiocarcinoma;Cholangiocarcinoma
- Austria, United States
- 2014-07-02
Not recruiting
- Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
- Germline BRCA1/2 Mutations and;Metastatic Adenocarcinoma of the Pancreas
- Australia, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom, United States
- 2014-06-06
Not recruiting
- Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: ENZAMET
- Prostate Cancer
- Australia, Canada, Ireland, New Zealand, United Kingdom, United States of America
- 2014-01-29
Not recruiting
- A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection
- Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics;Hepatitis C Virus Infection;Human Immunodeficiency Virus Infection;Chronic Hepatitis C;Compensated Cirrhosis and Non-cirrhotics
- Australia, Canada, France, Germany, Italy, New Zealand, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2013-09-06
Not recruiting
- Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
- Newly Diagnosed;Advanced Ovarian Cancer;FIGO Stage III-IV;BRCA Mutation;Complete Response;Partial Response;First Line Platinum Chemotherapy
- Australia, Brazil, Canada, China, France, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, United Kingdom, United States
- 2013-04-30
Not Recruiting
- Phase 1 clinical study to assess safety of single infusions of rADAMTS13 (BAX930) in humans and to evaluate distribution and elimination of rADAMTS13 (BAX930) from the human body after administration at 3 different dose levels in patients diagnosed with severe hereditary TTP
- Subjects diagnosed with hereditary thrombotic thrombocytopenic purpura (TTP) MedDRA version: 18.0 Level: LLT Classification code 10043562 Term: Thrombocytopenic purpura, thrombotic System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Germany, Japan, Poland, United Kingdom, United States
- 2012-11-12
Not recruiting
- Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
- Platinum Sensitive Ovarian Cancer;Ovarian Cancer
- United States
- 2016-11-22
Not recruiting
- Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- FGFR1 Gene Amplification;FGFR1 Gene Mutation;FGFR2 Gene Amplification;FGFR2 Gene Mutation;FGFR3 Gene Amplification;FGFR3 Gene Mutation;Recurrent Squamous Cell Lung Carcinoma;Stage IV Squamous Cell Lung Carcinoma AJCC v7
- Canada, United States
- 2016-11-14
Not recruiting
- A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website
- Tobacco Use;Smoking Cessation;Smoking, Tobacco;Tobacco Smoking;Guided Imagery
- United States
- 2016-11-10
Not recruiting
- Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer
- Metastatic Pancreatic Cancer
- United States
- 2016-11-02
Not Recruiting
- The Utility of Hyperacetylated HMGB1 as Tumor Marker of Malignant Mesothelioma; a prospective observational study
- Malignant Mesothelioma
- Japan, North America
- 2016-11-01